[Parkinson disease. The clinical picture and therapy].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000547:Amantadine / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000378:metabolism / Q000627:therapeutic use*; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology
D000319:Adrenergic beta-Antagonists; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D001971:Bromocriptine; D007980:Levodopa; D000547:Amantadine
Morbus Parkinson. Klinik und Therapie.